Lanzamiento Enero 2027

Ensayo controlado aleatorizado1991Financiación no declarada

Creatine phosphate (Neoton) as an additive to St. Thomas' Hospital cardioplegic solution (Plegisol). Results of a clinical study

Chambers DJ, Braimbridge MV, Kosker S, Yamada M, Jupp RA, Crowther A

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 7 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
1991-01-01 · Eur J Cardiothorac Surg · vol. 5 · número 2 · págs. 74–81
Editorial
Oxford University Press
Citado
17 citas · más que el 88% de estudios similares · 2.3× el promedio de su campo
Referencias
18 trabajos
Acceso
De pago
Áreas de investigación
Cardiac and Coronary Surgery Techniques · Cardiac Ischemia and Reperfusion · Transplantation: Methods and Outcomes
Palabras clave
phosphocreatine, cardioplegia, St. Thomas' Hospital cardioplegic solution, cardioprotection, coronary artery bypass grafting, reperfusion arrhythmias, creatine kinase-MB, myocardial infarction, postoperative cardiac function, birefringence, inotropic support
MeSH
myocardium, aorta, heart valves, humans, myocardial reperfusion injury, calcium chloride, bicarbonates, potassium chloride, sodium chloride, magnesium, isoenzymes, creatine kinase, phosphocreatine, cardioplegic solutions, electrocardiography, heart arrest, induced, coronary artery bypass, time factors, adult, aged, middle aged, arrhythmias, cardiac

6 autores

  • David J. Chambers
  • M.V. Braimbridge
  • S KOSKER
  • Muneaki Yamada
  • R A Jupp
  • A. Crowther

Resumen

El texto original del estudio, en el idioma en que se publicó.

Experimentally, creatine phosphate (CP) added to St. Thomas' Hospital cardioplegic solution (STH) improved post-ischaemic recovery of cardiac function in the rat heart. We investigated the effect of adding CP (10.0 mmol/l) to STH. Fifty open-heart surgery patients were randomized into control (STH) and treated (STH + CP) groups (25 per group). Patients underwent (a) monitoring for peri- and postoperative arrhythmias (48-h Holter monitoring). (b) quantitative birefringence assessment of intraoperative myocardial protection in left and right ventricular biopsies sampled at start of bypass (pre-isch.), end of bypass (end-isch.) and after 10 min reperfusion (post-isch.), and (c) measurement of serum creatine kinase-MB isozyme (CK-MB) values for up to 4 days postoperatively; results were assessed with respect to (d) haemodynamics and postoperative clinical outcome. Inotropic support (adrenaline) was required in three patients (12%) from each group; no patient died. All patients required defibrillation, and the number of direct current shocks required for sinus rhythm was the same in each group. The occurrence and incidence of reperfusion-induced arrhythmias were the same in both groups. Serum CK and CK-MB values were similar throughout the sampling period in both groups of patients; one patient in the control group had raised CK-MB levels postoperatively, but perioperative infarction was not indicated by the electrocardiogram.(ABSTRACT TRUNCATED AT 250 WORDS)

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.